A detailed history of Pathstone Holdings, LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Pathstone Holdings, LLC holds 38,541 shares of VRTX stock, worth $18.1 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares
38,541
Previous 37,003 4.16%
Holding current value
$18.1 Million
Previous $15.5 Million 16.79%
% of portfolio
0.08%
Previous 0.07%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$392.81 - $485.53 $604,141 - $746,745
1,538 Added 4.16%
38,541 $18.1 Million
Q1 2024

May 13, 2024

BUY
$407.69 - $446.08 $1.82 Million - $1.99 Million
4,472 Added 13.75%
37,003 $15.5 Million
Q4 2023

Feb 14, 2024

BUY
$343.0 - $410.68 $11.2 Million - $13.4 Million
32,531 New
32,531 $13.2 Million

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $121B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Pathstone Holdings, LLC Portfolio

Follow Pathstone Holdings, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pathstone Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pathstone Holdings, LLC with notifications on news.